Codiak Biosciences Stock


Sign up today and learn more about Codiak Biosciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Fidelity Investments


San Francisco CA, US

Total Funding


About Codiak Biosciences Stock

Codiak Biosciences is developing exosomes, natural vesicles that mediate inter-cellular communication, as both a powerful therapeutic modality and an advanced diagnostic system. Codiak is building a world-class team and has generated and acquired foundational intellectual property that will allow it to capitalize on the unique potential of exosome biology.


Funding History

November 2015$33.2M
November 2015$64.2M
November 2017$76.5M


Chief Executive Officer

Doug Williams

Chief Business Officer

Richard Brudnick

Chief Financial Officer

Linda C. Bain

Scientific Co-Founder

Raghu Kalluri

Scientific Co-Founder

Eric Lander

Chief Scientist

Jan Lötvall


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: